Skip to main content

New publication on pseudotumoral lesions in MS co-authored by Prof. Jelena Drulovic

Prof. Jelena Drulovic, ParadigMS Foundation Board Member, has co-authored the article Etiology and Characteristics of Pseudotumoral Lesions and Tumefactive Demyelination in Multiple Sclerosis, published in Elsevier in November 2024.We are pleased to invite you to explore this publication, which provides valuable insights into the complexities of pseudotumoral MS lesions and their clinical implications.IntroductionThe article titled “Etiology and Characteristics of Pseudotumoral Lesions and Tumefactive Demyelination in Multiple Sclerosis” delves into the complex nature of tumefactive...

Continue reading

ParadigMS Expert Prof. Magd Zakaria co-authors study on predicting disease activity in relapsing-remitting MS

We are delighted to share a new article Development and Validation of a Scoring System for Predicting Disease Activity in Treatment-Naïve Patients with Relapsing-Remitting Multiple Sclerosis co-authored by Prof. Magd Zakaria, a ParadigMS Foundation Board Member. This collaborative research, published in the journal Multiple Sclerosis and Related Disorders (MSARD Journal) on 16th January 2025, highlights significant findings that contribute to the growing body of knowledge on prognosis in multiple sclerosis (MS) management.IntroductionRelapsing-remitting multiple sclerosis (RRMS) presents substantial...

Continue reading

ParadigMS: Advancing MS knowledge and care

At ParadigMS Foundation, we are dedicated to empowering healthcare professionals with the tools and knowledge they need to improve outcomes in multiple sclerosis (MS) care. Through high-quality educational resources and collaborative opportunities, we aim to address the challenges faced by the MS community and drive meaningful progress in the field.Explore Our 2025 InitiativesThis year, we’ll be hosting webinars, meetings, interviews, e-learning modules and more to delve into the most pressing topics in MS care. Visit us regularly to stay informed and up to date on the latest developments and...

Continue reading

2024: ParadigMS for Multiple Sclerosis Care

Dear colleagues, supporters, and friends,As 2024 ends, we celebrate a year of progress at ParadigMS, marked by impactful events like the Belgian Symposium, the International Neuroimmunology Conference and the Pre-MENACTRIMS Symposium. These achievements reflect our shared commitment to advancing MS care and education worldwide.Looking ahead to 2025, we are excited to launch initiatives focused on emerging therapies, advanced diagnostics, and practical tools to empower healthcare professionals. Together, we will continue to drive meaningful improvements in MS management.We also mourn the loss...

Continue reading

Save the Date: National MS Meeting 2025

The Belgian Study Group for Multiple Sclerosis and ParadigMS Foundation are delighted to announce the National MS Meeting, taking place on Saturday, June 14th, 2025, at the Faculty Club in Leuven, Belgium (morning session).This year’s theme, “New Diagnostic Criteria: Radiologic Elements,” invites Belgian neurologists, trainees, and researchers to explore key topics in MS clinical care. Please find below the draft of the programme: Check our event page for more details:Event page

Continue reading

ParadigMS Foundation at MENACTRIMS Congress: A Focus on MS Care

The ParadigMS Foundation proudly participated in the MENACTRIMS Congress 2024, a leading event that brings together experts, researchers, and clinicians from the Middle East, North Africa, and beyond to advance the understanding and treatment of multiple sclerosis (MS). As part of this esteemed gathering, ParadigMS hosted a Pre-MENACTRIMS Congress Symposium, sponsored by Merck. This symposium featured three expert-led sessions that addressed key challenges and advancements in MS care.Topics Covered in the ParadigMS Symposium:Epidemiology of MS in the Middle EastProf. Saeed Bohlega explored the...

Continue reading

FAQs

Is ParadigMS for free?

Yes, a ParadigMS subscription is free for healthcare practitioniers. 

Do subscriptions auto-renew?
Your subscription will automatically renew on yearly basis. If you cancel your plan, it will not renew at the end of your subscription cycle. 
I am a representative from industry, can I subscribe?

Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material. 

What happens if I subscribe as a HCP if I am not?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately. 
I am a patient, can I subscribe?

ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.

Why should I subscribe to ParadigMS's e-platform?

Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.

How can I cancel my subscription?
You can cancel your subscription in your account settings. 
Can I financially support ParadigMS?

Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.